Oncobiologics: Cantor Fitzgerald Healthcare Conference (Oncobiologics) - Jul 30, 2016 - "The pharmacokinetic data for Humira and ONS-3010 showed similar profiles over time"; "The results from the immunogenicity showed similar profiles in the three treatment arms"; "The most frequently occurring adverse event (AE) was local administration site irritation-either burning sensation or pain upon injection at the injection site-which was observed less frequently in the ONS-3010 treatment group"
P1 data • Biosimilar
|